title: Comment on: Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study.
authors.forename: J
authors.initials: J
authors.lastname: Bateman
authors.forename: R
authors.initials: R
authors.lastname: Penfold
authors.forename: S P
authors.initials: SP
authors.lastname: Rigby
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects*; D051437:Renal Insufficiency / Q000150:complications*
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate